Search research articles
Contact Us
Filters
Showing results (141-150 of 201) with videos related to
Page
of 21
Sort By:
American Journal of Clinical Oncology
|
April 8, 2006
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer
Albert Craig Lockhart, Gillian F Cropp, Jordan D Berlin, et al.
Future Oncology (London, England)
|
May 11, 2019
ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases
Debu Tripathy, Sara M Tolaney, Andrew D Seidman, et al.
Cancer Chemotherapy and Pharmacology
|
August 30, 2011
Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors
Elaine T Lam, Sanjay Goel, Larry J Schaaf, et al.
Food Microbiology
|
September 19, 2012
Development of a consensus method for culture of Clostridium difficile from meat and its use in a survey of U.S. retail meats
Brandi Limbago, Angela D Thompson, Sharon A Greene, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 11, 2012
Assessment of physician knowledge and practices concerning Shiga toxin-producing Escherichia coli infection and enteric illness, 2009, Foodborne Diseases Active Surveillance Network (FoodNet)
Paula Clogher, Sharon Hurd, Dina Hoefer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 24, 2011
Transmission of 2009 pandemic influenza A (H1N1) at a Public University--Delaware, April-May 2009
Alice Guh, Carrie Reed, L Hannah Gould, et al.
The Journal of Biological Chemistry
|
February 17, 2012
The transcription factor Erg controls endothelial cell quiescence by repressing activity of nuclear factor (NF)-κB p65
Nicola H Dryden, Andrea Sperone, Silvia Martin-Almedina, et al.
Anti-Cancer Drug Design
|
July 11, 2000
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent
D B Mendel, A D Laird, B D Smolich, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2004
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101
P C Adamson, S M Blaney, B C Widemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
Melissa Johnson, Anthony El-Khoueiry, Navid Hafez, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 201) with videos related to
Sort By:
Page
of 21
American Journal of Clinical Oncology
|
April 8, 2006
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer
Albert Craig Lockhart, Gillian F Cropp, Jordan D Berlin, et al.
Future Oncology (London, England)
|
May 11, 2019
ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases
Debu Tripathy, Sara M Tolaney, Andrew D Seidman, et al.
Cancer Chemotherapy and Pharmacology
|
August 30, 2011
Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors
Elaine T Lam, Sanjay Goel, Larry J Schaaf, et al.
Food Microbiology
|
September 19, 2012
Development of a consensus method for culture of Clostridium difficile from meat and its use in a survey of U.S. retail meats
Brandi Limbago, Angela D Thompson, Sharon A Greene, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 11, 2012
Assessment of physician knowledge and practices concerning Shiga toxin-producing Escherichia coli infection and enteric illness, 2009, Foodborne Diseases Active Surveillance Network (FoodNet)
Paula Clogher, Sharon Hurd, Dina Hoefer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 24, 2011
Transmission of 2009 pandemic influenza A (H1N1) at a Public University--Delaware, April-May 2009
Alice Guh, Carrie Reed, L Hannah Gould, et al.
The Journal of Biological Chemistry
|
February 17, 2012
The transcription factor Erg controls endothelial cell quiescence by repressing activity of nuclear factor (NF)-κB p65
Nicola H Dryden, Andrea Sperone, Silvia Martin-Almedina, et al.
Anti-Cancer Drug Design
|
July 11, 2000
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent
D B Mendel, A D Laird, B D Smolich, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2004
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101
P C Adamson, S M Blaney, B C Widemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
Melissa Johnson, Anthony El-Khoueiry, Navid Hafez, et al.
Page
of 21